What's ahead for the UK NHS?

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.448, 2004-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is screening for type 2 diabetes mellitus worth it for the UK NHS?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 328, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Single Technology Appraisals by NICE: Are They Delivering Faster Guidance to the NHS?

By Barham Leela

PharmacoEconomics, Vol. 26, Iss. 12, 2008-01 ,pp. : 1037-1043

Adis International

Access to resources Recommend Favorite

Rationing and the UK NHS: rational debate or rationalisation?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 270, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Should the UK NHS embrace disease management?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 252, 2000-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Another Year Over, So What Lies Ahead?

By Wright Tracey

Pharmaceutical & Diagnostic Innovation, Vol. 3, Iss. 12, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite